Efficient Method for the Synthesis of Benzimidazoquinazoline Derivatives with Three‐Point DiversityFootnote

CDRI Communication No. 7150.

References

• Michael , P. J. 2005 . Quinoline, quinazoline and acridone alkaloids . Nat. Prod. Rep. , 22 : 627 – 646 .
   PubMed Web of Science ®Google Scholar
• Ciardiello , F. 2000 . Epidermal growth factor receptor tyrosine kinase inhibitors as anti‐cancer agents . Drugs , 60 ( suppl. 1 ) : 25 – 32 .
   PubMed Web of Science ®Google Scholar
• Tsou , H. R. , Mamuya , N. , Johnson , B. D. , Reich , M. F. , Gruber , B. C. , Ye , F. , Nilakantan , R. , Shen , R. , Discafani , C. , DeBlanc , R. , Davis , R. , Koehn , F. E. , Greenberger , L. M. , Wang , Y. F. and Wissner , A. 2001 . 6‐Substituted‐4‐(3‐bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) aand human epidermal growth factor receptor (HER‐2) tyrosine kinases with enhanced antitumor activity . J. Med. Chem. , 44 : 2719 – 2734 .
   PubMed Web of Science ®Google Scholar
• Smaill , J. B. , Rewcastle , G. W. , Loo , J. A. , Greis , K. D. , Chan , O. H. , Reyner , E. L. , Lipka , E. , Showalter , H. D. , Vincent , P. W. , Elliott , W. L. and Denny , W. A. 2000 . Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4‐(phenylamino)quinazoline‐ and 4‐(phenylamino)pyrido[3,2‐d]pyrimidine‐6‐acrylamides bearing additional solubilizing functions . J. Med. Chem. , 43 : 1380 – 1397 .
   PubMed Web of Science ®Google Scholar
• Mannschreck , A. , Koller , H. , Stuhler , G. , Davies , M. A. and Traber , J. 1984 . The enantiomers of methaqualone and their unequal anticonvulsive activity . Eur. J. Med. Chem. , 19 : 381 – 383 .
   Web of Science ®Google Scholar
• Molamas , M. S. and Miller , J. 1991 . Quinazolineacetic acids and related analogs as aldose reductase inhibitors . J. Med. Chem. , 34 : 1492 – 1503 .
   Google Scholar
• Fry , D. W. 1994 . Protein tyrosine kinases as therapeutic targets in cancer chemotherapy and recent advances in the development of new inhibitors . Expert Opin. Invest. Drugs , 3 : 577 – 595 .
   Google Scholar
• Gibson , K. H. , Grundy , W. , Godfrey , A. A. , Woodburn , J. R. , Asthon , S. E. , Curry , B. J. , Scarlett , L. , Barker , A. J. and Brown , D. S. 1997 . Epidermal growth factor receptor tyrosine kinase: Structure‐activity relationships and antitumour activity of novel quinazolines . Bioorg. Med. Chem. Lett. , 7 : 2723 – 2728 .
   Web of Science ®Google Scholar
• Myers , M. R. , Setzer , N. N. , Spada , A. P. , Zulli , A. L. , Hsu , C. Y. J. , Zilberstein , A. , Johnson , S. E. , Hook , L. E. and Jacoski , M. V. 1997 . The preparation and SAR of 4‐(anilino), 4‐(phenoxy), and 4‐(thiophenoxy)‐quinazolines: Inhibitors of p56lck and EGF‐R tyrosine kinase activity . Bioorg. Med. Chem. Lett. , 7 : 417 – 420 .
   Web of Science ®Google Scholar
• Grover , R. , Kesarwani , A. P. , Srivastava , G. K. , Kundu , B. and Roy , R. 2005 . Base catalyzed intramolecular transamidation of 2‐aminoquinazoline derivatives on solid phase . Tetrahedron , 61 : 5011 – 5018 .
   Web of Science ®Google Scholar
• Kesarwani , A. P. , Grover , R. , Roy , R. and Kundu , B. 2005 . Solid‐phase synthesis of imidazoquinazolinone derivatives with three‐point diversity . Tetrahedron , 61 : 629 – 635 .
   Google Scholar
• Srivastava , G. K. , Kesarwani , A. P. , Grover , R. K. , Srinivasan , T. , Roy , R. and Kundu , B. 2003 . Solid phase synthesis of 2‐aminoquinazoline‐based compounds . J. Comb. Chem. , 5 : 769 – 774 .
   PubMedGoogle Scholar
• Kesarwani , A. P. , Srivastava , G. K. , Rastogi , S. K. and Kundu , B. 2002 . Solid‐phase synthesis of quinazolin‐4(3H)‐ones with three‐point diversity . Tetrahedron Lett. , 43 : 5579 – 5581 .
   Web of Science ®Google Scholar
• Kundu , B. , Partani , P. , Duggineni , S. and Sawant , D. 2005 . Solid‐phase synthesis of 2‐aminoquinazolinone derivatives with two‐ and three‐point diversity . J Comb. Chem. , 7 : 909 – 915 .
   Google Scholar
• Spence , C. M. and Bergden , R. N. 1994 . Anagrelide a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of thrombocythaemia . Drugs , 47 : 809 – 822 .
   Google Scholar
• Venuti , M. C. , Stephenson , R. A. , Alvarez , R. , Bruno , J. J. and Strosberg , A. M. 1988 . Inhibitors of cyclic AMP phosphodiesterase 3. Synthesis and biological evaluation of pyrido and imidazolyl analogs of 1,2,3,5‐tetrahydro‐2‐oxoimidazo[2,1‐b]quinazoline . J. Med. Chem. , 31 : 2136 – 2145 .
   Google Scholar
• Katritzky , A. R. , Tymoshenko , D. O. , Monteux , D. , Vvedensky , V. , Nikonov , G. , Cooper , C. B. and Deshpande , M. 2000 . A new three‐carbon synthon for efficient synthesis of benzannelated and 1‐(2‐arylethenyl) heterocycles . J. Org. Chem. , 65 : 8059 – 8062 .
   PubMed Web of Science ®Google Scholar
• Perron , D. , Conlon , D. , Bousquet , P. F. and Robinson , S. P. 1997 . Benzimidazo[1,2‐c]quinazoline dimers as potential antitumor agent . J. Heterocycl. Chem. , 34 : 807 – 812 .
   Google Scholar
• Molina , P. , Alajarin , M. and Vidal , A. 1988 . Heterocyclic synthesis via a tandem aza‐Wittig reaction/heterocumulene‐mediated annulation reaction. New methodology for the preparation of quinazoline derivatives . Tetrahedron Lett. , 29 : 3849 – 3852 .
   Web of Science ®Google Scholar
• Molina , P. , Alajarin , M. and Vidal , A. 1989 . New methodology for the preparation of quinazoline derivatives via tandem aza‐wittig/heterocumulene‐mediated annulation. Synthesis of 4(3H)‐quinazolinones, benzimidazo[1,2‐c] quinazolines, quinazolino[3,2‐a]quinazolines and benzothiazolo[3,2‐c]quinazolines . Tetrahedron , 45 : 4263 – 4286 .
   Web of Science ®Google Scholar
• Beaulieu , P. L. , Haché , B. and Moos , E. V. 2003 . A practical Oxone®‐mediated, high‐throughput, solution‐phase synthesis of benzimidazoles from 1,2‐phenylenediamines and aldehydes and its application to preparative scale synthesis . Synthesis , : 1683 – 1692 .
   Google Scholar
• Nicolaou , K. C. , Trujillo , J. I. , Jandeleit , B. , Chibale , K. , Rosenfed , M. , Diefenbach , B. , Cheresh , D. A. and Goodman , S. L. 1998 . Design, synthesis and biological evaluation of nonpeptide integrin antagonists . Bioorg. Med. Chem. , 6 : 1185 – 1208 .
   Google Scholar
• Peterlin‐Mašič , L. and Kikelj , D. 2001 . Arginine mimetics . Tetrahedron , 57 : 7073 – 7105 .
   Web of Science ®Google Scholar
• Poss , M. A. , Iwanowicz , E. , Reid , J. A. , Lin , J. and Gu , Z. 1992 . A mild and efficient method for the preparation of guanidines . Tetrahedron Lett. , 33 : 5933 – 5936 .
   Web of Science ®Google Scholar
• Iwanowicz , E. , Poss , M. A. and Lin , J. 1993 . Preparation of N,N′‐bis‐tert‐butoxycarbonylthiourea . Synth. Commun. , 23 : 1443 – 1445 .
   Web of Science ®Google Scholar
• Cherkaoui , O. , Essassi , E. M. and Zniber , R. 1991 . Hétérocyclisation des 2‐aminoalkyl (et aryl) benzimidazoles en catalyse par transfert de phase . Bull. Soc. Chim. Fr. , : 255 – 259 .
   Google Scholar
• Grimmett , M. R. 1984 . “ Imidazoles and their benzo derivatives ” . In Comprehensive Heterocyclic Chemistry Vol. 5 , 345 New York : Pergamon .
   Google Scholar